Kyma Med

Kfar Saba, Israel Founded: 2008 • Age: 18 yrs Acquired By ZOLL AEDs
Remote monitoring solutions for chronic cardiac patients are provided.

About Kyma Med

Kyma Med is a Healthcare company based in Kfar Saba (Israel) founded in 2008, and was acquired by ZOLL AEDs in September 2015. Remote monitoring solutions for chronic cardiac patients are provided. It operates in the Healthcare and Technology sectors. Kyma Med has raised $10 million across 1 funding round from investors including ZOLL AEDs, Elron Ventures and Ganot Capital. The company was acqui-hired. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Remote Monitoring.

Company details

Kyma Medical Technologies develops patient monitoring solutions to improve care of patients suffering from chronic cardiac illnesses. The company has developed a proprietary technology for the detection and monitoring of changes in fluid contents, based on a proprietary RF sensing technology. Kymas solutions aim at providing healthcare professionals with accurate information on the patients clinical status for support of medical decision-making. Kymas technology is currently applied via external use, and a subcutaneous approach is under development, thus meeting the needs of a variety of patient populations. The Kyma µ-Cor is CE Mark-approved for monitoring of one or more of the following clinical parameters: Thoracic Fluid Content, ECG, heart rate, respiratory rate, activity and body posture. As of November 2016, the device is not FDA approved and still under investigation in the US.

  • Headquarters Kfar Saba, Israel
  • Stage Acquired
  • Sectors
    Healthcare
    Technology
  • Website kyma-med.com
  • Social LinkedIn
  • Acquired by ZOLL AEDs (Sep 2015)
Key Metrics
  • Total Equity Funding
    $10M (USD)

    in 1 rounds

  • Latest Funding Round
    $10M (USD), Series A

    Oct 2013

  • Investors
    ZOLL AEDs

    & 3 more

  • Acquired by
    ZOLL AEDs

    (Sep 2015)

Funding Insights of Kyma Med

Kyma Med has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series A round of $10 million completed in October 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $10M
  • Total Rounds 1
  • Last Round Series A β€” $10M
  • First Round $10M

    (Oct 2013)

  • Investors Count 3

All 1 funding rounds of Kyma Med with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2013$10MSeries A––
Valuation history

4 investors in total: 4 institutional.

Investors in Kyma Med

Kyma Med has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include ZOLL AEDs, Elron Ventures and Ganot Capital.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Ganot Capital is focused on senior care investments.
1964ganotcapital.comUnited States
Early-growth technology startups are supported by Elron Ventures.
1962rdc.co.ilTel Aviv, Israel
Venture capital firm focused on early-stage technologies companies
1962elronventures.comTel Aviv, Israel
Medical devices and software for emergency care are developed.
1983zoll.comChelmsford, United States
Premium access

Investor details for Kyma Med

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Kyma Med

3 dated milestones of Kyma Med across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Kyma Med is founded.
  2. Funding First funding round of $10.0M.
  3. Exit Acquired by ZOLL AEDs.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Kyma Med

Premium access

Complete news archive for Kyma Med

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kyma Med

Kyma Med was founded in 2008 and raised its 1st funding round 5 years after it was founded.

Kyma Med is headquartered in Kfar Saba, Israel. It is registered at Kfar Saba, Central District, Israel.

Kyma Med is a funded company, having raised a total of $10M across 1 funding round to date. The company's 1st funding round was a Series A of $10M, raised on Oct 2013.

Kyma Medical Technologies develops patient monitoring solutions to improve care of patients suffering from chronic cardiac illnesses. The company has developed a proprietary technology for the detection and monitoring of changes in fluid contents, based on a proprietary RF sensing technology. Kymas solutions aim at providing healthcare professionals with accurate information on the patients clinical status for support of medical decision-making. Kymas technology is currently applied via external use, and a subcutaneous approach is under development, thus meeting the needs of a variety of patient populations. The Kyma Β΅-Cor is CE Mark-approved for monitoring of one or more of the following clinical parameters: Thoracic Fluid Content, ECG, heart rate, respiratory rate, activity and body posture. As of November 2016, the device is not FDA approved and still under investigation in the US.

Kyma Med has 4 investors. Key investors include ZOLL AEDs, Elron Ventures, Ganot Capital, and Elron Ventures.

Yes. Kyma Med was acquired by ZOLL AEDs in September 2015.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available